Tributary Capital Management’s AngioDynamics ANGO Stock Holding History

Tributary Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-684,833	Closed	-$6.96M	–	206
2020 Q2	$6.96M	Buy	684,833 +50,289	+8%	+$518K	0.59%	60
2020 Q1	$6.62M	Sell	634,544 -16,855	-3%	-$212K	0.68%	56
2019 Q4	$10.4M	Sell	651,399 -26,265	-4%	-$401K	0.73%	60
2019 Q3	$12.5M	Sell	677,664 -26,055	-4%	-$510K	0.91%	54
2019 Q2	$13.9M	Sell	703,719 -780	-0.1%	-$15.9K	0.98%	47
2019 Q1	$16.1M	Buy	704,499 +200,829	+40%	+$4.36M	1.17%	39
2018 Q4	$10.1M	Buy	503,670 +6,895	+1%	+$143K	0.93%	50
2018 Q3	$10.8M	Buy	496,775 +95,380	+24%	+$2.12M	0.82%	56
2018 Q2	$8.93M	Buy	+401,395	New	+$8.2M	0.7%	62

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Tributary Capital Management's ANGO Position: Q3 2020 in Review

Tributary Capital Management sold out of AngioDynamics (ANGO) in Q3 2020, closing a stake of 684,833 shares — an estimated $6.96M sold.

Tributary Capital Management first reported a position in ANGO in Q2 2018 and held it in 9 quarters. The position peaked at $16.1M in Q1 2019. 138 funds tracked by Wall St. Rank hold ANGO as of Q3 2020.

Tributary Capital Management reported no remaining AngioDynamics position as of Q3 2020 after selling out during the quarter.
Tributary Capital Management sold 684,833 AngioDynamics shares in Q3 2020, an estimated $6.96M.
Tributary Capital Management first reported a position in AngioDynamics in Q2 2018 and held it in 9 quarters.
Tributary Capital Management's AngioDynamics position peaked at $16.1M in Q1 2019.
138 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2020.

Based on Tributary Capital Management's 13F filing for Q3 2020, filed 13 Oct 2020.